Editorial: Somatostatin receptor-based scintigraphy and antitumor treatment - An expanding vista?

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 10, 2000, Pages 3507-3508

  Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

CANCER THERAPY; DRUG EFFECT; DRUG TARGETING; EDITORIAL; ENDOCRINE TUMOR; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; SCINTIGRAPHY; TUMOR LOCALIZATION;

EID: 0033767516     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.10.6958     Document Type: Editorial

References (21)

1. Peptide therapy. Recent advances in the use of somatostatin and other peptide receptor agonists and antagonists
2. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues
3. 3]-octreotide: The Rotterdam experience with more than 1000 patients
4. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors
5. Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - A prospective study
6. Somatostatin and its receptor family
7. 3]octreotide by somatostatin receptor-positive cells in vitro and in vivo: Implications for somatostatin receptor-targeted radio-guided surgery
8. Progressive nuclear translocation of somatostatin analogs
9. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues
10. 3-octreotide: Preliminary report in cancer patients
11. The role of radioactive somatostatin and its analogues in the control of tumor growth
12. New somatostatin analogues for radiotherapy of somatostatin receptor expressing tumours
13. Carcinoid and pancreatic endocrine tumors. Recent advances in molecular pathogenesis, localization and treatment
14. Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis
15. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
16. The significance of somatostatin analogues in the antiproliferative treatment of carcinomas
17. Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs
18. Human ovarian cancers express somatostatin receptors
19. Receptor targeting for tumor localization and therapy with radiopeptides
20. Diagnostic applications of radiolabeled peptides in nuclear endocrinology
21. 1]-octreotide scintigraphy in patients with hormone-refractory prostatic adenocarcinoma can predict therapy outcome with octreotide treatment: A pilot study